Patients diagnosed with septic shock according to Surviving Sepsis Campaign Guidelines 2021 will be included in the study.~Groups will be formed after the measurement of intra-abdominal pressure (IAP). Those with IAP of less than 8 mmHg will be assigned to the control group and treated according to mean arterial pressure. Those with IAP greater than 8 mmHg will be divided into two groups by computer-generated randomization (via randomizer.org). One group (Group MAP) will be treated according to mean arterial pressure and the other group (Group APP) will be treated according to abdominal perfusion pressure. In Group APP, maximum arterial pressure will be targeted as 130/85 mmHg.~All patients will receive appropriate antibiotic therapy, fluid therapy and, vasopressor treatment as recommended in Surviving Sepsis Campaign Guidelines 2021 and abdominal pressure measurement will be repeated every 12 hours.~Age, sex, body mass index, cause of sepsis and comorbidities of all patients will be recorded.~Patients will be followed for liver and kidney function tests, procalcitonin and lactate levels, daily SOFA (Sequential Organ Failure Assessment) calculations, length of stay (days), length of stay in mechanical ventilator (days), and 30 and 90 days mortality.
Septic shock is a clinical condition that is defined as a subset of sepsis that causes very high mortality and morbidity.~Surviving sepsis campaign guideline states that the target mean arterial pressure should be 65 mmHg and above in septic shock patients. It is known that abdominal pressure increases and perfusion of intra-abdominal organs decreases in septic shock patients.~With this study, we aim to investigate the effects of targeted abdominal perfusion pressure (60 mmHg and above) on renal injury, reversal of renal injury, liver functions and ultimately mortality in patients with septic shock.